These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 16204081

  • 1. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer.
    Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, Chiao PJ, Philip PA, Abbruzzese J, Sarkar FH.
    Cancer Res; 2005 Oct 01; 65(19):9064-72. PubMed ID: 16204081
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer.
    Banerjee S, Zhang Y, Wang Z, Che M, Chiao PJ, Abbruzzese JL, Sarkar FH.
    Int J Cancer; 2007 Feb 15; 120(4):906-17. PubMed ID: 17131310
    [Abstract] [Full Text] [Related]

  • 3. Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts.
    Mohammad RM, Banerjee S, Li Y, Aboukameel A, Kucuk O, Sarkar FH.
    Cancer; 2006 Mar 15; 106(6):1260-8. PubMed ID: 16475211
    [Abstract] [Full Text] [Related]

  • 4. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.
    Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB.
    Cancer Res; 2007 Apr 15; 67(8):3853-61. PubMed ID: 17440100
    [Abstract] [Full Text] [Related]

  • 5. Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer.
    Banerjee S, Kaseb AO, Wang Z, Kong D, Mohammad M, Padhye S, Sarkar FH, Mohammad RM.
    Cancer Res; 2009 Jul 01; 69(13):5575-83. PubMed ID: 19549912
    [Abstract] [Full Text] [Related]

  • 6. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.
    Li Y, Ahmed F, Ali S, Philip PA, Kucuk O, Sarkar FH.
    Cancer Res; 2005 Aug 01; 65(15):6934-42. PubMed ID: 16061678
    [Abstract] [Full Text] [Related]

  • 7. NEMO peptide inhibits the growth of pancreatic ductal adenocarcinoma by blocking NF-κB activation.
    Zhuang Z, Li H, Lee H, Aguilar M, Gocho T, Ju H, Iida T, Ling J, Fu J, Wu M, Sun Y, Lu Y, Chiao PJ.
    Cancer Lett; 2017 Dec 28; 411():44-56. PubMed ID: 28951128
    [Abstract] [Full Text] [Related]

  • 8. Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo.
    Wang SJ, Gao Y, Chen H, Kong R, Jiang HC, Pan SH, Xue DB, Bai XW, Sun B.
    Cancer Lett; 2010 Jul 01; 293(1):99-108. PubMed ID: 20137856
    [Abstract] [Full Text] [Related]

  • 9. Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo.
    Wang YW, Wang SJ, Zhou YN, Pan SH, Sun B.
    J Cancer Res Clin Oncol; 2012 May 01; 138(5):785-97. PubMed ID: 22270965
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma.
    Chen D, Niu M, Jiao X, Zhang K, Liang J, Zhang D.
    Int J Mol Sci; 2012 May 01; 13(1):1186-1208. PubMed ID: 22312312
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB.
    El-Rayes BF, Ali S, Ali IF, Philip PA, Abbruzzese J, Sarkar FH.
    Cancer Res; 2006 Nov 01; 66(21):10553-9. PubMed ID: 17079479
    [Abstract] [Full Text] [Related]

  • 14. Vitamin E δ-tocotrienol augments the antitumor activity of gemcitabine and suppresses constitutive NF-κB activation in pancreatic cancer.
    Husain K, Francois RA, Yamauchi T, Perez M, Sebti SM, Malafa MP.
    Mol Cancer Ther; 2011 Dec 01; 10(12):2363-72. PubMed ID: 21971120
    [Abstract] [Full Text] [Related]

  • 15. Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo.
    Wang ZH, Chen H, Guo HC, Tong HF, Liu JX, Wei WT, Tan W, Ni ZL, Liu HB, Lin SZ.
    Int J Oncol; 2011 Nov 01; 39(5):1123-31. PubMed ID: 21743963
    [Abstract] [Full Text] [Related]

  • 16. Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K/Akt/NF-κB pathways.
    Li J, Liang X, Yang X.
    Oncol Rep; 2012 Aug 01; 28(2):501-10. PubMed ID: 22641480
    [Abstract] [Full Text] [Related]

  • 17. Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer.
    Ali S, Banerjee S, Schaffert JM, El-Rayes BF, Philip PA, Sarkar FH.
    J Cell Biochem; 2010 May 01; 110(1):171-81. PubMed ID: 20213764
    [Abstract] [Full Text] [Related]

  • 18. Piperlongumine Suppresses Growth and Sensitizes Pancreatic Tumors to Gemcitabine in a Xenograft Mouse Model by Modulating the NF-kappa B Pathway.
    Wang Y, Wu X, Zhou Y, Jiang H, Pan S, Sun B.
    Cancer Prev Res (Phila); 2016 Mar 01; 9(3):234-44. PubMed ID: 26667450
    [Abstract] [Full Text] [Related]

  • 19. [Role of nuclear factor-kappaB on emodin-induced sensitization of pancreatic cancer to gemcitabine].
    Liu A, Hu YS, Wang ZH, Tang LL, Ke PY, Lin SZ.
    Yao Xue Xue Bao; 2011 Feb 01; 46(2):146-52. PubMed ID: 21542284
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.